Global Prokaryotic Recombinant Protein Market Research Report 2023

Publication ID:

PB503235171

Publication Date:

March 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Prokaryotic recombinant proteins are proteins that are encrypted by genes (recombinant DNA) and cloned into the prokaryotic system (E. coli). The high specificity and low immunogenicity of prokaryotic recombinant proteins make them suitable for chronic therapy and several autoimmune diseases.
Highlights
The global Prokaryotic Recombinant Protein market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Prokaryotic Recombinant Protein is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Prokaryotic Recombinant Protein is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Prokaryotic Recombinant Protein include Eli Lilly and Company, Merck, Roche, Prospec-Tany Technogene, Cusabio Technology, Randox Laboratories, Batavia Biosciences, Geno Technology and Kaneka and Eurogentec, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prokaryotic Recombinant Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prokaryotic Recombinant Protein.
The Prokaryotic Recombinant Protein market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prokaryotic Recombinant Protein market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prokaryotic Recombinant Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Eli Lilly and Company
Merck
Roche
Prospec-Tany Technogene
Cusabio Technology
Randox Laboratories
Batavia Biosciences
Geno Technology
Kaneka and Eurogentec
Abnova Corporation
Cayman Chemical Company
Geltor IndieBio
Bioclone
Segment by Type
Hormones
Interferons
Interleukins
Others
Segment by Application
Biotechnology Companies
Research institutes
Contract Research organizations
Hospital
Laboratories
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prokaryotic Recombinant Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prokaryotic Recombinant Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Prokaryotic Recombinant Protein Market Overview
1.1 Product Overview and Scope of Prokaryotic Recombinant Protein
1.2 Prokaryotic Recombinant Protein Segment by Type
1.2.1 Global Prokaryotic Recombinant Protein Market Value Comparison by Type (2023-2029)
1.2.2 Hormones
1.2.3 Interferons
1.2.4 Interleukins
1.2.5 Others
1.3 Prokaryotic Recombinant Protein Segment by Application
1.3.1 Global Prokaryotic Recombinant Protein Market Value by Application: (2023-2029)
1.3.2 Biotechnology Companies
1.3.3 Research institutes
1.3.4 Contract Research organizations
1.3.5 Hospital
1.3.6 Laboratories
1.3.7 Others
1.4 Global Prokaryotic Recombinant Protein Market Size Estimates and Forecasts
1.4.1 Global Prokaryotic Recombinant Protein Revenue 2018-2029
1.4.2 Global Prokaryotic Recombinant Protein Sales 2018-2029
1.4.3 Global Prokaryotic Recombinant Protein Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Prokaryotic Recombinant Protein Market Competition by Manufacturers
2.1 Global Prokaryotic Recombinant Protein Sales Market Share by Manufacturers (2018-2023)
2.2 Global Prokaryotic Recombinant Protein Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Prokaryotic Recombinant Protein Average Price by Manufacturers (2018-2023)
2.4 Global Prokaryotic Recombinant Protein Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Prokaryotic Recombinant Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prokaryotic Recombinant Protein, Product Type & Application
2.7 Prokaryotic Recombinant Protein Market Competitive Situation and Trends
2.7.1 Prokaryotic Recombinant Protein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prokaryotic Recombinant Protein Players Market Share by Revenue
2.7.3 Global Prokaryotic Recombinant Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prokaryotic Recombinant Protein Retrospective Market Scenario by Region
3.1 Global Prokaryotic Recombinant Protein Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Prokaryotic Recombinant Protein Global Prokaryotic Recombinant Protein Sales by Region: 2018-2029
3.2.1 Global Prokaryotic Recombinant Protein Sales by Region: 2018-2023
3.2.2 Global Prokaryotic Recombinant Protein Sales by Region: 2024-2029
3.3 Global Prokaryotic Recombinant Protein Global Prokaryotic Recombinant Protein Revenue by Region: 2018-2029
3.3.1 Global Prokaryotic Recombinant Protein Revenue by Region: 2018-2023
3.3.2 Global Prokaryotic Recombinant Protein Revenue by Region: 2024-2029
3.4 North America Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.4.1 North America Prokaryotic Recombinant Protein Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Prokaryotic Recombinant Protein Sales by Country (2018-2029)
3.4.3 North America Prokaryotic Recombinant Protein Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.5.1 Europe Prokaryotic Recombinant Protein Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Prokaryotic Recombinant Protein Sales by Country (2018-2029)
3.5.3 Europe Prokaryotic Recombinant Protein Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.6.1 Asia Pacific Prokaryotic Recombinant Protein Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Prokaryotic Recombinant Protein Sales by Country (2018-2029)
3.6.3 Asia Pacific Prokaryotic Recombinant Protein Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.7.1 Latin America Prokaryotic Recombinant Protein Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Prokaryotic Recombinant Protein Sales by Country (2018-2029)
3.7.3 Latin America Prokaryotic Recombinant Protein Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prokaryotic Recombinant Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa Prokaryotic Recombinant Protein Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Prokaryotic Recombinant Protein Sales by Country (2018-2029)
3.8.3 Middle East and Africa Prokaryotic Recombinant Protein Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prokaryotic Recombinant Protein Sales by Type (2018-2029)
4.1.1 Global Prokaryotic Recombinant Protein Sales by Type (2018-2023)
4.1.2 Global Prokaryotic Recombinant Protein Sales by Type (2024-2029)
4.1.3 Global Prokaryotic Recombinant Protein Sales Market Share by Type (2018-2029)
4.2 Global Prokaryotic Recombinant Protein Revenue by Type (2018-2029)
4.2.1 Global Prokaryotic Recombinant Protein Revenue by Type (2018-2023)
4.2.2 Global Prokaryotic Recombinant Protein Revenue by Type (2024-2029)
4.2.3 Global Prokaryotic Recombinant Protein Revenue Market Share by Type (2018-2029)
4.3 Global Prokaryotic Recombinant Protein Price by Type (2018-2029)
5 Segment by Application
5.1 Global Prokaryotic Recombinant Protein Sales by Application (2018-2029)
5.1.1 Global Prokaryotic Recombinant Protein Sales by Application (2018-2023)
5.1.2 Global Prokaryotic Recombinant Protein Sales by Application (2024-2029)
5.1.3 Global Prokaryotic Recombinant Protein Sales Market Share by Application (2018-2029)
5.2 Global Prokaryotic Recombinant Protein Revenue by Application (2018-2029)
5.2.1 Global Prokaryotic Recombinant Protein Revenue by Application (2018-2023)
5.2.2 Global Prokaryotic Recombinant Protein Revenue by Application (2024-2029)
5.2.3 Global Prokaryotic Recombinant Protein Revenue Market Share by Application (2018-2029)
5.3 Global Prokaryotic Recombinant Protein Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Corporation Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Eli Lilly and Company Prokaryotic Recombinant Protein Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Prokaryotic Recombinant Protein Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Roche Prokaryotic Recombinant Protein Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Prospec-Tany Technogene
6.4.1 Prospec-Tany Technogene Corporation Information
6.4.2 Prospec-Tany Technogene Description and Business Overview
6.4.3 Prospec-Tany Technogene Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Prospec-Tany Technogene Prokaryotic Recombinant Protein Product Portfolio
6.4.5 Prospec-Tany Technogene Recent Developments/Updates
6.5 Cusabio Technology
6.5.1 Cusabio Technology Corporation Information
6.5.2 Cusabio Technology Description and Business Overview
6.5.3 Cusabio Technology Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cusabio Technology Prokaryotic Recombinant Protein Product Portfolio
6.5.5 Cusabio Technology Recent Developments/Updates
6.6 Randox Laboratories
6.6.1 Randox Laboratories Corporation Information
6.6.2 Randox Laboratories Description and Business Overview
6.6.3 Randox Laboratories Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Randox Laboratories Prokaryotic Recombinant Protein Product Portfolio
6.6.5 Randox Laboratories Recent Developments/Updates
6.7 Batavia Biosciences
6.6.1 Batavia Biosciences Corporation Information
6.6.2 Batavia Biosciences Description and Business Overview
6.6.3 Batavia Biosciences Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Batavia Biosciences Prokaryotic Recombinant Protein Product Portfolio
6.7.5 Batavia Biosciences Recent Developments/Updates
6.8 Geno Technology
6.8.1 Geno Technology Corporation Information
6.8.2 Geno Technology Description and Business Overview
6.8.3 Geno Technology Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Geno Technology Prokaryotic Recombinant Protein Product Portfolio
6.8.5 Geno Technology Recent Developments/Updates
6.9 Kaneka and Eurogentec
6.9.1 Kaneka and Eurogentec Corporation Information
6.9.2 Kaneka and Eurogentec Description and Business Overview
6.9.3 Kaneka and Eurogentec Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Kaneka and Eurogentec Prokaryotic Recombinant Protein Product Portfolio
6.9.5 Kaneka and Eurogentec Recent Developments/Updates
6.10 Abnova Corporation
6.10.1 Abnova Corporation Corporation Information
6.10.2 Abnova Corporation Description and Business Overview
6.10.3 Abnova Corporation Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Abnova Corporation Prokaryotic Recombinant Protein Product Portfolio
6.10.5 Abnova Corporation Recent Developments/Updates
6.11 Cayman Chemical Company
6.11.1 Cayman Chemical Company Corporation Information
6.11.2 Cayman Chemical Company Prokaryotic Recombinant Protein Description and Business Overview
6.11.3 Cayman Chemical Company Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Cayman Chemical Company Prokaryotic Recombinant Protein Product Portfolio
6.11.5 Cayman Chemical Company Recent Developments/Updates
6.12 Geltor IndieBio
6.12.1 Geltor IndieBio Corporation Information
6.12.2 Geltor IndieBio Prokaryotic Recombinant Protein Description and Business Overview
6.12.3 Geltor IndieBio Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Geltor IndieBio Prokaryotic Recombinant Protein Product Portfolio
6.12.5 Geltor IndieBio Recent Developments/Updates
6.13 Bioclone
6.13.1 Bioclone Corporation Information
6.13.2 Bioclone Prokaryotic Recombinant Protein Description and Business Overview
6.13.3 Bioclone Prokaryotic Recombinant Protein Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Bioclone Prokaryotic Recombinant Protein Product Portfolio
6.13.5 Bioclone Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prokaryotic Recombinant Protein Industry Chain Analysis
7.2 Prokaryotic Recombinant Protein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prokaryotic Recombinant Protein Production Mode & Process
7.4 Prokaryotic Recombinant Protein Sales and Marketing
7.4.1 Prokaryotic Recombinant Protein Sales Channels
7.4.2 Prokaryotic Recombinant Protein Distributors
7.5 Prokaryotic Recombinant Protein Customers
8 Prokaryotic Recombinant Protein Market Dynamics
8.1 Prokaryotic Recombinant Protein Industry Trends
8.2 Prokaryotic Recombinant Protein Market Drivers
8.3 Prokaryotic Recombinant Protein Market Challenges
8.4 Prokaryotic Recombinant Protein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Eli Lilly and Company
Merck
Roche
Prospec-Tany Technogene
Cusabio Technology
Randox Laboratories
Batavia Biosciences
Geno Technology
Kaneka and Eurogentec
Abnova Corporation
Cayman Chemical Company
Geltor IndieBio
Bioclone

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂